Match!
Katharina Laubner
University of Freiburg
EndocrinologyInsulinType 2 Diabetes MellitusDiabetes mellitusMedicine
82Publications
7H-index
158Citations
What is this?
Publications 85
Newest
#1Natascha Roehlen (University of Freiburg)H-Index: 1
#2Katharina Laubner (University of Freiburg)H-Index: 7
Last. Jochen Seufert (University of Freiburg)H-Index: 22
view all 9 authors...
Background The duodenal-jejunal bypass liner (DJBL) represents a novel endoscopic minimally invasive treatment option for obesity-associated type 2 diabetes (T2D), affecting body weight and metabolic control. Until now, the effects of DJBL on cardiovascular risk have never been investigated.
Source
Last. Katharina Laubner (University of Freiburg)H-Index: 7
view all 2 authors...
In 70–90 % der Falle von Gestationsdiabetes mellitus (GDM) kann eine zielgerechte Stoffwechseleinstellung mit Basismasnahmen erzielt werden. Zur konservativen Therapie zahlen Lebensstilverbesserung, Selbstkontrolle der Blutglukosespiegel, vermehrte korperliche Bewegung, Ernahrungsumstellung, Schulungen und Abbau von „distress“. Konnen die Blutglukosezielwerte nicht erreicht werden, ist eine Pharmakotherapie mit Insulin die primare Behandlung, die tagliche Anfangsdosis sollte auf das aktuelle Kor...
Source
#1Laura Potasso (University of Freiburg)
#2Nikolaos Perakakis (University of Freiburg)H-Index: 9
Last. Katharina Laubner (University of Freiburg)H-Index: 7
view all 9 authors...
Background The single nucleotide polymorphism in TCF7L2 rs7903146 is associated with an increased risk of type 2 diabetes mellitus and gestational diabetes mellitus. Mechanisms by which this mutation acts, and its impact on the clinical course of the diseases remain unclear. Here we investigated the clinical impact of the T risk allele in women with gestational diabetes mellitus. Methods We genotyped the C/T polymorphism in 164 Caucasian women with GDM (German n=114; Greek n=50). The impact of t...
Source
#1LaubnerKatharina (University of Freiburg)
#2SinglerEva (University of Freiburg)
Last. SeufertJochen (University of Freiburg)
view all 6 authors...
Abstract Background: Recent studies demonstrate variable results of the accuracy with which patch pumps infuse insulin. Aim of this evaluation was to measure dose accuracies of the patch pump mylif...
Source
#2Günter PäthH-Index: 9
Last. Jochen SeufertH-Index: 18
view all 4 authors...
Source
#1Katharina LaubnerH-Index: 7
Last. Jochen SeufertH-Index: 18
view all 7 authors...
Introduction: The duodenal-jejunal bypass liner (DJBL) is an antiresorptive endoscopic treatment option for type 2 diabetes (T2DM) and obesity. The effects of DJBL on cardiovascular risk parameters remain elusive. Methods: We implanted in 71 patients with T2DM and metabolic syndrome a DJBL for 9-12 months. At implantation, 3 months, explantation, 3 and 6 months follow-up, data on blood sugar, body weight, blood pressure and lipid status were collected. Serum samples were analysed for dynamics of...
Source
#1Nicole Prinz (University of Ulm)H-Index: 4
#2A. Zolin (University of Milan)H-Index: 11
view all 12 authors...
Source
#1Fabian Frank (University of Freiburg)H-Index: 4
#2Frederike Bjerregaard (University of Freiburg)H-Index: 2
Last. Sebastian Voigt-Radloff (University of Freiburg)H-Index: 8
view all 18 authors...
Background Multimorbid older adults suffering from a long-term health condition like depression, diabetes mellitus type 2, dementia or frailty are at high risk of losing their autonomy. Disability and multimorbidity in the older population are associated with social inequality and lead to soaring costs. Our local, collaborative, stepped and personalised care management for older people with chronic diseases (LoChro-Care) aims at improving outcomes for older multimorbid patients with chronic cond...
Source
#1Christian StoykowH-Index: 3
#2Katharina LaubnerH-Index: 7
Last. Juri RufH-Index: 20
view all 6 authors...
Source
#1Ute Schäfer-GrafH-Index: 5
#2Ulrich GembruchH-Index: 48
Last. Dagmar Bancher-Todesca (University of Vienna)H-Index: 17
view all 12 authors...
A team of experts from the fields of gynaecology and obstetrics, diabetology, internal medicine, paediatrics and midwifery from Germany, Austria and Switzerland produced a new version of the existing S3 guideline on gestational diabetes. It replaces the recommendations of the German Association for Gynaecology and Obstetrics and the German Diabetes Association on the diagnosis and treatment of gestational diabetes from 2011 and is valid for the three German-speaking countries. The primary aim of...
3 CitationsSource
123456789